Literature DB >> 31712925

ASO Author Reflections: Delays in the Treatment of DCIS-What are the Costs?

William H Ward1, Richard J Bleicher2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31712925      PMCID： PMC6952533          DOI： 10.1245/s10434-019-08062-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Does time to definitive treatment matter in patients with ductal carcinoma in situ?

Authors:  Gloria R Sue; Donald R Lannin; Brigid Killelea; Theodore Tsangaris; Anees B Chagpar
Journal:  Am Surg       Date:  2013-06       Impact factor: 0.688

2.  Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.

Authors:  Lars J Grimm; Marc D Ryser; Ann H Partridge; Alastair M Thompson; Jeremy S Thomas; Jelle Wesseling; E Shelley Hwang
Journal:  Ann Surg Oncol       Date:  2017-08-09       Impact factor: 5.344

Review 3.  The molecular journey from ductal carcinoma in situ to invasive breast cancer.

Authors:  Lisa Wiechmann; Henry M Kuerer
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

4.  Time to Surgery and Breast Cancer Survival in the United States.

Authors:  Richard J Bleicher; Karen Ruth; Elin R Sigurdson; J Robert Beck; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Eric I Chang; Neal S Topham; Brian L Egleston
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

5.  Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.

Authors:  Lotte E Elshof; Marjanka K Schmidt; Emiel J Th Rutgers; Flora E van Leeuwen; Jelle Wesseling; Michael Schaapveld
Journal:  Ann Surg       Date:  2018-05       Impact factor: 12.969

6.  Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.

Authors:  William H Ward; Lyudmila DeMora; Elizabeth Handorf; Elin R Sigurdson; Eric A Ross; John M Daly; Allison A Aggon; Richard J Bleicher
Journal:  Ann Surg Oncol       Date:  2019-09-27       Impact factor: 5.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.